Molecular epidemiological analysis of Saffold cardiovirus genotype 3 from upper respiratory infection patients in Taiwan

J Clin Virol. 2015 Sep:70:7-13. doi: 10.1016/j.jcv.2015.06.100. Epub 2015 Jun 27.

Abstract

Background: Saffold cardiovirus (SAFV) belongs to the Cardiovirus genus of Picornaviridae family, and may be a relevant new human pathogen; Thus far, eleven genotypes have been identified. The SAFV type 3 (SAFV-3) is thought to be the major genotype and is detected relatively frequently in children with acute gastroenteritis and respiratory illness. The epidemiology and pathogenicity of SAFV-3 remain unclear.

Objectives: To investigate the genomic and epidemiologic profiles of SAFV-3 infection in Taiwan.

Study design: Virus was detected in respiratory samples from children suffering for URI. SAFV-3 isolates were detected by isolation on cell culture and IF assay. The molecular typing was performed by RT-PCR and was sequenced to compare with reference strains available in the NCBI GeneBank. Serum samples were collected from 2005 to 2013 in Taiwan for seroprevalence investigation.

Results: A total of 226 specimens collected from children with URIs, 22 (9.73%) were positive for SAFV-3. The majority of SAFV-3 infections were found in children less than 6 years of age (14 of 22, 63.6%). Genetic analysis of VP1 coding region of Taiwanese isolates shown an 83.2-97.7% difference from other available SAFV-3 sequences in NCBI GenBank. Phylogenetic analysis revealed there is three genetic groups of SAFV-3 co-circulated in Taiwan during the study period. In addition, seroprevalence investigation results indicated that SAFV-3 infection occurs early in life and 43.7-77.8% of children aged between 6 months to 9 years old, had neutralizing antibodies against SAFV-3.

Conclusion: SAFV-3 may have circulated in Taiwan for some time and it appears to be one of the etiological agents responsible for URIs in children.

Keywords: Molecular epidemiology; Saffold virus; Taiwan; Upper respiratory infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antibodies, Neutralizing / blood
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Cardiovirus / classification
  • Cardiovirus / genetics*
  • Cardiovirus / immunology
  • Cardiovirus / isolation & purification
  • Cardiovirus Infections / diagnosis
  • Cardiovirus Infections / epidemiology*
  • Cardiovirus Infections / virology*
  • Cell Line
  • Child
  • Child, Preschool
  • Female
  • Genetic Variation
  • Genome, Viral
  • Genotype*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Phylogeny
  • Prevalence
  • Respiratory Tract Infections / diagnosis
  • Respiratory Tract Infections / epidemiology*
  • Respiratory Tract Infections / virology*
  • Seroepidemiologic Studies
  • Taiwan / epidemiology

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral